CUSIP 26818M108 · who reports it, how much, and how much it matters to them
35 of the 720 hedge fund managers we track reported shares of Dyne Therapeutics, Inc. (Nasdaq: DYN) on Form 13F for 30 June 2026. Between them they reported USD 627m. The largest position belongs to Orbimed Advisors, at USD 72m. The manager with the most riding on it is Palo Alto Investors, where it is 5.1% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Orbimed Advisors1 fund on PPLI.com | USD 72m | 1.3% |
| 2 | Armistice Capital1 fund on PPLI.com | USD 69m | 0.8% |
| 3 | Perceptive Advisors6 funds on PPLI.com | USD 60m | 0.9% |
| 4 | Logos Global Management1 fund on PPLI.com | USD 57m | 2.4% |
| 5 | Samlyn Capital8 funds on PPLI.com | USD 39m | 0.6% |
| 6 | Sofinnova Investments1 fund on PPLI.com | USD 37m | 1.9% |
| 7 | Palo Alto Investors6 funds on PPLI.com | USD 37m | 5.1% |
| 8 | Deep Track Capital1 fund on PPLI.com | USD 33m | 0.5% |
| 9 | Marshall Wace LLP84 funds on PPLI.com | USD 33m | 0.0% |
| 10 | Polar Capital LLP26 funds on PPLI.com | USD 29m | 0.1% |
| 11 | Citadel Advisors32 funds on PPLI.com | USD 25m | 0.0% |
| 12 | Rock Springs Capital Management2 funds on PPLI.com | USD 21m | 1.0% |
| 13 | Braidwell12 funds on PPLI.com | USD 20m | 0.8% |
| 14 | Baker Bros. Advisors2 funds on PPLI.com | USD 18m | 0.1% |
| 15 | Artisan Partners1 fund on PPLI.com | USD 15m | 0.0% |
| 16 | Millennium Management6 funds on PPLI.com | USD 9.6m | 0.0% |
| 17 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 8.8m | 0.4% |
| 18 | Renaissance Technologies13 funds on PPLI.com | USD 8m | 0.0% |
| 19 | Moore Capital Management7 funds on PPLI.com | USD 6.8m | 0.1% |
| 20 | Squarepoint Ops7 funds on PPLI.com | USD 6.7m | 0.0% |
| 21 | Sphera Funds Management1 fund on PPLI.com | USD 4.4m | 0.6% |
| 22 | HighVista Strategies27 funds on PPLI.com | USD 3.8m | 0.9% |
| 23 | Adage Capital Management1 fund on PPLI.com | USD 3.3m | 0.0% |
| 24 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 3m | 0.0% |
| 25 | Jain Global1 fund on PPLI.com | USD 2.6m | 0.0% |
| 26 | D. E. Shaw & Co.15 funds on PPLI.com | USD 1.3m | 0.0% |
| 27 | Mangrove Partners Im1 fund on PPLI.com | USD 1.1m | 0.1% |
| 28 | Atom Investors1 fund on PPLI.com | USD 957,000 | 0.1% |
| 29 | Brevan Howard Capital Management39 funds on PPLI.com | USD 827,000 | 0.0% |
| 30 | Neo Ivy Capital Management1 fund on PPLI.com | USD 698,000 | 0.2% |
| 31 | Boothbay Fund Management2 funds on PPLI.com | USD 680,000 | 0.0% |
| 32 | Lion Point Capital1 fund on PPLI.com | USD 400,000 | 1.9% |
| 33 | Two Sigma Investments35 funds on PPLI.com | USD 315,000 | 0.0% |
| 34 | Persistent Asset Partners10 funds on PPLI.com | USD 124,000 | 0.0% |
| 35 | The Quarry1 fund on PPLI.com | USD 577 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Palo Alto Investors | USD 37m | 5.1% |
| 2 | Logos Global Management | USD 57m | 2.4% |
| 3 | Lion Point Capital | USD 400,000 | 1.9% |
| 4 | Sofinnova Investments | USD 37m | 1.9% |
| 5 | Orbimed Advisors | USD 72m | 1.3% |
| 6 | Rock Springs Capital Management | USD 21m | 1.0% |
| 7 | Perceptive Advisors | USD 60m | 0.9% |
| 8 | HighVista Strategies | USD 3.8m | 0.9% |
| 9 | Armistice Capital | USD 69m | 0.8% |
| 10 | Braidwell | USD 20m | 0.8% |
Dyne Therapeutics, Inc. trades under the symbol DYN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 26818M108.
35 of the 720 hedge fund managers PPLI.com tracks reported Dyne Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Orbimed Advisors (USD 72m), Armistice Capital (USD 69m), Perceptive Advisors (USD 60m), Logos Global Management (USD 57m) and Samlyn Capital (USD 39m).
35 managers in our coverage reported it, and between them they run 407 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Palo Alto Investors, where the position was 5.1% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Dyne Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.